López-Hernández, R.; de la Torre-Álamo, M.M.; García-Bueno, B.; Baroja-Mazo, A.; Fenoy, F.J.; Cuevas, S.
Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target. Antioxidants 2025, 14, 121.
https://doi.org/10.3390/antiox14020121
AMA Style
López-Hernández R, de la Torre-Álamo MM, García-Bueno B, Baroja-Mazo A, Fenoy FJ, Cuevas S.
Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target. Antioxidants. 2025; 14(2):121.
https://doi.org/10.3390/antiox14020121
Chicago/Turabian Style
López-Hernández, Rubén, María Magdalena de la Torre-Álamo, Belén García-Bueno, Alberto Baroja-Mazo, Francisco Jose Fenoy, and Santiago Cuevas.
2025. "Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target" Antioxidants 14, no. 2: 121.
https://doi.org/10.3390/antiox14020121
APA Style
López-Hernández, R., de la Torre-Álamo, M. M., García-Bueno, B., Baroja-Mazo, A., Fenoy, F. J., & Cuevas, S.
(2025). Inflammasomes in Alzheimer’s Progression: Nrf2 as a Preventive Target. Antioxidants, 14(2), 121.
https://doi.org/10.3390/antiox14020121